caplacizumab
SpainDrugs containing this active substance
-
It is used to treat an episode of acquired thrombotic thrombocytopenic purpura in adults and adolescents aged 12 years and older who weigh at least 40 kg. This medicine helps prevent the formation of blood clots by preventing platelets from clumping together.
Form: powder and solvent for solution for injection
Active substance Dosage caplacizumab 12,5 mg Manufacturer: Ablynx